Quick Answer
Propanc Biopharma, Inc. reported Research And Development Expense of $223.7 thousand for the year ending 2025.
- Propanc Biopharma, Inc. showed a decrease of -9.8% in Research And Development Expense from 2024 to 2025.
- This data is from Propanc Biopharma, Inc.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), Propanc Biopharma, Inc.'s Research And Development Expense has declined by 42.0%.
- Historical annual values: Fiscal year 2025: $223.7 thousand | Fiscal year 2024: $248.1 thousand | Fiscal year 2023: $247.9 thousand | Fiscal year 2022: $256.1 thousand | Fiscal year 2021: $231.0 thousand | Fiscal year 2020: $180.0 thousand | Fiscal year 2019: $260.3 thousand | Fiscal year 2018: $1.83 million | Fiscal year 2017: $971.8 thousand | Fiscal year 2016: $1.45 million | Fiscal year 2015: $134.3 thousand | Fiscal year 2014: $8.2 thousand | Fiscal year 2013: $12.3 thousand | Fiscal year 2012: $5.3 thousand | Fiscal year 2011: $385.8 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: